Cadrenal Therapeutics Inc (CVKD)
0.4905
+0.03
(+5.48%)
USD |
NASDAQ |
May 03, 16:00
0.4926
0.00 (0.00%)
After-Hours: 20:00
Cadrenal Therapeutics Enterprise Value: -0.5503M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | -0.5503M |
| May 02, 2024 | -0.9585M |
| May 01, 2024 | -1.127M |
| April 30, 2024 | -1.359M |
| April 29, 2024 | -1.181M |
| April 26, 2024 | -1.511M |
| April 25, 2024 | -1.621M |
| April 24, 2024 | -1.544M |
| April 23, 2024 | -1.575M |
| April 22, 2024 | -1.882M |
| April 19, 2024 | -1.974M |
| April 18, 2024 | -1.522M |
| April 17, 2024 | -1.652M |
| April 16, 2024 | -2.161M |
| April 15, 2024 | -1.919M |
| April 12, 2024 | -1.796M |
| April 11, 2024 | -1.423M |
| April 10, 2024 | -1.322M |
| April 09, 2024 | -1.860M |
| April 08, 2024 | -0.2382M |
| April 05, 2024 | 0.5463M |
| April 04, 2024 | 1.332M |
| April 03, 2024 | 1.171M |
| April 02, 2024 | 1.507M |
| April 01, 2024 | 1.507M |
| Date | Value |
|---|---|
| March 28, 2024 | 1.363M |
| March 27, 2024 | 1.843M |
| March 26, 2024 | 1.981M |
| March 25, 2024 | 1.683M |
| March 22, 2024 | 2.003M |
| March 21, 2024 | 1.683M |
| March 20, 2024 | 1.203M |
| March 19, 2024 | 0.7223M |
| March 18, 2024 | 0.5623M |
| March 15, 2024 | 1.010M |
| March 14, 2024 | 1.119M |
| March 13, 2024 | 0.9785M |
| March 12, 2024 | 0.8823M |
| March 11, 2024 | 2.016M |
| March 08, 2024 | 2.317M |
| March 07, 2024 | 1.918M |
| March 06, 2024 | -0.1434M |
| March 05, 2024 | 0.0493M |
| March 04, 2024 | 0.2577M |
| March 01, 2024 | 0.6145M |
| February 29, 2024 | 0.7656M |
| February 28, 2024 | 0.3749M |
| February 27, 2024 | -0.5628M |
| February 26, 2024 | -0.2372M |
| February 23, 2024 | -0.1981M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-3.770M
Minimum
Nov 13 2023
48.50M
Maximum
Jan 20 2023
8.041M
Average
6.785M
Median
Enterprise Value Benchmarks
| Tenax Therapeutics Inc | -1.772M |
| Syra Health Corp | 6.490M |
| Minerva Neurosciences Inc | -24.34M |
| Adverum Biotechnologies Inc | 119.95M |
| Genprex Inc | -2.076M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.144M |
| Total Expenses (Quarterly) | 1.264M |
| EPS Diluted (Quarterly) | -0.05 |
| Earnings Yield | -140.7% |